Intercept Pharmaceuticals, Inc. et al v. Lupin Limited et al
| Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe Limited |
| Lupin Pharmaceuticals, Inc. and Lupin Limited |
| 1:2020cv01155 |
| August 28, 2020 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 16, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Deepro Mukerjee, Lance Soderstrom, Joseph M. Janusz, Jitendra Malik, Ph.D. and Guylaine Hache - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: #1 Mukerjee Pro Hac Certification, #2 Soderstrom Pro Hac Certification, #3 Janusz Pro Hac Certification, #4 Malik Pro Hac Certification, #5 Hache Pro Hac Certification)(Haney, Megan) |
| Filing 9 WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited: For Lupin Limited waiver sent on 9/15/2020, answer due 11/16/2020. (Blumenfeld, Jack) |
| Filing 8 WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited: For Lupin Pharmaceuticals, Inc. waiver sent on 9/15/2020, answer due 11/16/2020. (Blumenfeld, Jack) |
| Pro Hac Vice Attorneys Deepro R. Mukerjee, Lance A. Soderstrom, Joseph M. Janusz, Jitendra Malik, Guylaine Hache for Lupin Limited and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
SO ORDERED re #10 MOTION for Pro Hac Vice Appearance of Attorney Deepro Mukerjee, Lance Soderstrom, Joseph M. Janusz, Jitendra Malik, Ph.D. and Guylaine Hache filed by Lupin Limited, Lupin Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 9/16/2020. (dlw)
|
| Pro Hac Vice Attorney Mary Swears for Intercept Pharma Europe Limited and Intercept Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01154-MN, 1:20-cv-01155-MN, 1:20-cv-01214-UNA, 1:20-cv-01215-UNA(kmd) |
|
SO ORDERED re (7 in 1:20-cv-01154-MN, 7 in 1:20-cv-01215-UNA, 7 in 1:20-cv-01214-UNA, 7 in 1:20-cv-01155-MN) MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy Cobb, Laura Dolbow, and Mary Swears filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited, Intercept Pharma Europe Ltd. ORDERED by Judge Maryellen Noreika on 9/15/2020. (dlw)
|
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy Cobb, Laura Dolbow, and Mary Swears - filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.. (Tigan, Jeremy) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:20-cv-01154-MN, 1:20-cv-01155-MN (rjb) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (nmg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Intercept Pharmaceuticals, Inc. for Intercept Pharma Europe Limited filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc.. (nmg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2; 10,047,117 B2; 10,052,337 B2; 10,174,073 B2; 7,138,390 B2. (nmg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Not earlier than 7/16/2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/27/2023. (nmg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3162926.) - filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited. (Attachments: #1 Exhibit A-F, #2 Civil Cover Sheet)(nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
